Article info
PDFTrophoblastic Disease
Actinomycin D Versus Methotrexate-Folinic Acid as the Treatment of Stage I, Low-Risk Gestational Trophoblastic Neoplasia: A Randomized Controlled Trial
- Address correspondence and reprint requests to Arb-aroon Lertkhachonsuk, MD, Department of Obstetrics and Gynaecology, Faculty of Medicine, Ramathibodi Hospital, Rama VI Rd, Bangkok 10400, Thailand. E-mail: arbaroon{at}hotmail.com, raalk{at}mahidol.ac.th.
Citation
Actinomycin D Versus Methotrexate-Folinic Acid as the Treatment of Stage I, Low-Risk Gestational Trophoblastic Neoplasia: A Randomized Controlled Trial
Publication history
- First published July 1, 2009.
Online issue publication
December 03, 2018
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright © 2009 by IGCS and ESGO